ロード中...
ANTI-HLA ANTIBODIES AND PREEMPTIVE ANTIBODY-DIRECTED THERAPY AFTER LUNG TRANSPLANTATION
BACKGROUND: Because the development of donor-specific anti-HLA antibodies (DSA) after lung transplantation has been associated with acute and chronic rejection we implemented a clinical protocol to screen all recipients for DSA after transplantation and preemptively treat those who develop DSA with...
保存先:
主要な著者: | , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
2010
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2926224/ https://ncbi.nlm.nih.gov/pubmed/20558084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.healun.2010.05.006 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|